Former FDA Officials Say Fosamax Claims Aren't Barred

By Emily Field (May 30, 2023, 6:42 PM EDT) -- Former U.S. Food and Drug Administration officials told the Third Circuit if it rules that patients' claims that Merck failed to warn that its osteoporosis drug Fosamax caused certain fractures are preempted, drug companies would be encouraged to hold back safety data....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!